ZTS Q1 2017 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$52B

Q1 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.2B+5.9% YoY

Gross Profit

$767M62.3% margin

Operating Income

$368M29.9% margin

Net Income

$238M19.3% margin

EPS (Diluted)

$0.48

QoQ Revenue Growth

-3.6%

Cash Flow

Operating Cash Flow

$119M

Free Cash Flow

$77M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$7.6B

Total Liabilities

$6.0B

Stockholders' Equity

$1.6B

Cash & Equivalents

$629M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$1.2B	+5.9%
Gross Profit	$767M	$773M	-0.8%
Operating Income	$368M	$347M	+6.1%
Net Income	$238M	$204M	+16.7%

Revenue Segments

Dogs and Cats

$482M40%

Cattle

$386M32%

Swine

$160M13%

Poultry

$116M10%

Horses

$35M3%

Fish

$21M2%

Sheep and Other

$20M2%

Geographic Segments

International

$615M50%

UNITED STATES

$605M50%